Dutch Society of Nephrology Rotterdam, The Netherlands October 20, 1984  by unknown
Investigations into the role of the kidney in the hypertension of the
fawn-hooded rat. M. H. M. Kuijpers, E. Gruys, and W. de Jong.
Unilever Research Laboratorium, Vlaardingen, Institute for Veterinary
Pathology, and Rudolf Magnus Institute for Pharmacology, Utrecht,
The Netherlands. The fawn-hooded rat (FH rat) developed focal
glomerulosclerosis at the age of 2 to 3 months (males) and ap-
proximately 6 months (females). They died prematurely at 11 to 15
months of age with overt malignant nephrosclerosis. During the first
half year of life, glomeruli showed depositions of IgG, IgA, 1gM, C3,
and fibrinogen in a segmental pattern and mainly in mesangial areas.
Mesangial IgG and IgA are demonstrable already at the age of 5 weeks.
On electron microscopy no electron-dense deposits suggestive of im-
mune complexes were found. PRA was normal at 5 weeks and tended
to decline with age. Systolic BP was already increased at 5 weeks of age
and the final range was 120 to 260 mm Hg for individual animals at I
year. Concomitant with the rise in BP the severity of proteinuria
increased. From the age of about 35 weeks onward 24-hr proteinuria
values showed a bimodal distribution and two classes were formed: (1)
one with values less than 100 mg per day and (2) another with values
greater than 100 mg per day. This spontaneous bipartition was found in
any given group of FH rats and was also noticed for heart, kidneys,
liver, and spleen weights. Class 2 animals developed a more severe
hypertension, exceeding 220 mm Hg systolic at the final stage. Water
intake and urine volume during several weeks after weaning were
significantly increased in class 2 animals (P < 0.001). At 15 weeks there
were no longer any differences between class 1 and 2 animals. The
period of increased water turnover appeared to predict the final severity
of the hypertension in FH rats. Interestingly, class 2 animals did not
show the sharp decrease in water intake upon fasting during 24-hr as
observed in class I animals (and in normal rats), viz. diuresis and
drinking continue even when no food is consumed. These observations
indicate that volume regulation and/or renal water handling are aberrant
in the early developmental or prehypertensive phase of this form of
hypertension.
Anti-thymocyte antibodies and kidney antigens. W. M. Bagchus, J. T.
W. M. Vos, J. Rozing, P. J. Hoedemaeker, and W. W. Bakker.
Department of Pathology, State University Groningen, Department of
Internal Medicine, Erasmus University Rotterdam and Department of
Pathology, State University Leiden, Leiden, The Netherlands. Anti-
thymocyte serum (ATS), used as an immunosuppressive agent in
clinical transplantation, may contain nephritogenic antibodies (Abs),
which are thought to be induced by stromal contamination of the
inoculum used for immunization. However, in experimental situations
it has been shown recently that purified rat thyniocytes are able to elicit
nephritogenic Abs after injection into rabbits. This dual specificity has
also been described in polyclonal nephritogenic rabbit Abs raised
against tubular brushborder antigens. To investigate whether shared
epitopes between glomerular structures and thymocytes or rather
crossreacting antibodies are involved, we now have studied binding of
poly- and monoclonal anti-thymocyte antibodies in rat kidney using
immunofluorescence (IF) and immunoelectronmicroscopy (IEM).
Thoroughly absorbed polyclonal anti-rat thymocyte IgG (ARTS) and
monoclonal anti-rat thymocyte Abs (ER 4, ER 5, ER 14) were incubated
with rat kidney tissue in vitro or perfused 'ex vivo' into rat kidneys.
Rabbit anti-rat albumin and monoclonal anti-rat B cell Abs were used as
control Abs. IgG solutions in saline (10 ml containing 0.1 mg
antibody/mi) were perfused under standard conditions into the renal
artery of the blood-free rat kidney for 5 mm, followed by perfusion with
4 ml saline (2 mm). Kidneys were processed subsequently for IF and
IEM, using standard procedures. The results of in vitro incubation as
well as 'cx vivo' perfusion show mesangial and subepithelial localiza-
tion of both polyclonal and morioclonal anti-T cell Abs. Heterologous
IgG could be detected in the subepithelial immune aggregates using
IEM (peroxidase technique). Control Abs did not show binding in vitro
or ex vivo. Though binding of anti-T cell Abs to the mesangium has
been described before, so far, to our knowledge, binding of these Abs
to the GBM has not been reported. Although trapping mechanisms
cannot be excluded completely, it is likely that anti-T cell paratopes
recognize glomerular epitopes. Because it has been shown that 'one
shot' inoculation of ARTS into rats leads also to mesangial and
subepithelial localization for several weeks, it is concluded that
nephritogenicity of some batches of ATS may be due to recognition of
shared epitopes in kidney and thymocyte membranes.
Implications of the cross-reactivity of anti-DNA antibodies for the
pathogenesis of SLE. P. Faaber, G. P. M. Rjke, J. H. M. Berden, L. B.
A. Van de Putte, and P. J. A. Capel. Departments of Nephrology and
Rheumatology, St. Radboudziekenhuis, University of N/megen, Nij-
megen, The Netherlands. Deposition of circulating immune complexes
(CIC) is regarded as the major immunopathological mechanism opera-
tive in systemic lupus erythematosus (SLE). However, during sucrose
gradient fractionation of human (N = 5) and murine (N = 10) SLE sera
with a high Raji-cell binding (RCB) activity (range, 320 to 1800 gEq
AIgG), we found no evidence for CIC. On subsequent analysis we could
show that the RCB was caused by monomeric 7S IgG with anti-DNA
specificity. The binding of these anti-DNA antibodies is probably due to
cross-reactivity with phospholipids present in the cell membrane.
Furthermore, in sera from SLE patients (N = 30) and MRL/1 mice (N
= 10), we found antibodies against heparan sulphate, the major glycos-
aminoglycan constituent of the glomerular basement membrane. The
anti-heparan sulphate activity was caused by cross-reactivity of anti-
DNA antibodies because absorption of the sera with DNA removed the
anti-DNA activity together with the anti-heparan sulphate activity. In
addition, we have observed that two monoclonal anti-DNA antibodies
reacted with heparan sulphate in a similar way as with DNA. Anti-DNA
antibodies doted from MRL/1 kidneys reacted in vitro with heparan
sulphate. Therefore, it is concluded that due to the cross-reactivity of
anti-DNA antibodies a false positive Raji-cell binding can be found,
erroneously suggesting the presence of CIC and secondly, that the
presence of anti-DNA antibodies in the glomerular basement membrane
might be caused by direct in situ binding to heparan sulphate rather than
by deposition of CIC.
Disturbed phosphate homeostasis in spontaneously hypertensive rats.
R. J. M. Bindels, J. A. M. Geertsen, C. H. van Os, andJ. F. G. Slegers.
Department of Physiology, University of Ntjmegen, Nijmegen, The
Netherlands. Despite a well-documented disturbed Ca2 and para-
thyroid hormone (PTH) metabolism in human and experimental hyper-
tension, organic phosphate (P3 and magnesium metabolism have not
been characterized widely. Between 6 and 23 weeks of age spontane-
ously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) were
placed in metabolic cages. Repeated timed urine specimens and serum
for P, Ca2, and Mg2 were obtained. Urinary P, excretion (rmoles/24
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hr) was lower and urinary Mg2 excretion was higher in SHR compared
to the age-matched WKY from 6 weeks onward, followed by an
increased urinary Ca2 excretion in SHR from 16 weeks on. Mean-
while, serum P1 (mat) was lower in SHR from 6 weeks on, whereas
serum Ca2 and Mg2 were similar in both strains.
Age (wk)
6 WKY
SHR
12 WKY
SHR
20 WKY
SHR
Sp
-
SMg Sca
3.62 0.04
3,21 0.14*
2.97 0.03
2.62 0.07*
2.23 0.07
1.90 0.10*
0.96 0.03
0.84 0.03
0.97 0.05
1.02 0.02
1.07 0.03
1.01 0.03
2.59 0.07
2.40 0.03
2.34 0.02
2.45 0.03
2.39 0.02
2.35 0.03
Age(wk) U1V UMgV UcaV
6 WKY
SHR
12 WKY
SHR
20 WKY
SHR
141 18
20 5*
442 27
315 20*
605 15
445 16*
208 13
338 13*
198 17
270 18*
137 15
227 18*
55 4
57 4
24 I
25 2
17 I
27 1*
(Mean SEM; , P < 0.01).
The difference in P excretion between SHR and WKY could also be
demonstrated in brushborder membrane vesicles (BBMV) isolated from
the kidney cortex at all ages. For example, at 20 weeks, the kinetic
parameters of Na-dependent P1 transport in BBMV showed differ-
ences between both strains. Maximal transport capacity was higher (P
<0.01) in SHR (10.4 0.7 nmoles/min/mg protein), than in WKY (8.5
0.6 nmoles/min/mg protein). In contrast, the apparent affinity con-
stants were similar for both the WKY (61 4 rM) and SHR (61 5 ai)
strains. In conclusion, SHR suffers mainly from a disturbed phosphate
metabolism, localized in part in BBM from SHR kidney cortex, already
before hypertension is established. A hypercalciuria develops later in
the mature SHR and is obviously of minor importance in the pathogen-
esis of hypertension.
DDAVP (1-desamino-8-D-arginine vasopressin). Antagonism of the
pressor activity of endogenous vasopressin? F. H. M. Derkx, A. J. Man
in t Veld, and M. A. D. H. Schalekamp. Department of Internal
Medicine I, University Hospital Djkzigi, Rotterdam, The Netherlands.
The pressor effect of AVP is thought to be mediated by a calcium-
dependent mechanism (V1-receptor) whereas its antidiuretic effect
depends on cyclic AMP (V2-receptor). In the AVP-analogue DDAVP
the antidiuretic activity is retained but the pressor activity is lost. Thus,
DDAVP could be an antagonist on the V1-receptor. If so, DDAVP
might be used for assessing the role of endogenous AVP in blood
pressure regulation. The hypothesis was tested in the following models:
renin secretion by rabbit kidney slices, aggregation of human platelets,
and blood pressure and renin responses in normal volunteers (N = 12)
and patients with autonomic insufficiency (N 3). AVP l00 to lO
moles/liter caused a dose-dependent inhibition of renin secretion and
platelet aggregation. These effects were absent in a calcium-free milieu
or in the presence of the calcium-antagonist verapamil 5 x l0
moles/liter. DDAVP in concentrations up to l0 moles/liter had no
effect but shifted the dose-response curves of AVP to the right. AVP
infusion into normal human subjects is known to lower heart rate and
plasma renin with little change in blood pressure. DDAVP, 0.4 jg/kg, in
10 mm caused no change in systolic pressure but diastolic pressure was
lowered by 14 2mm Hg (mean SEM). Heart rate rose by 24 2 bpm
and renin rose from 21 4 to 57 9 sU/ml (P < 0.01). In the patients
with autonomic insufficiency both systolic and diastolic pressures fell
by 20 to 35 mm Hg without a change in heart rate. In one case the
exaggerated pressure response to AVP was shown to be attenuated by
DDAVP. These findings suggest that DDAVP is a competitive antago-
nist on the calcium-dependent V1-receptor. Blockade of this receptor
may have unmasked the pressure effect of endogenous AVP.
Anticytoplasmatic antibodies (ACPA) are a specific marker for active
Wegener granulomatosis. F. J. van der Woude, A. Wiik, S. Lobatto, L.
A. van Es, M. van der Giessen, G. K. van der Hem, and T. H. The.
Universities of Groningen and Leiden, The Netherlands, and
Rigshospitalet, Copenhagen, Denmark. Immune complex (IC) levels
were investigated (prospectively) in 19 patients with Wegener
granulomatosis (WG). IC were studied with the fluid phase Clq-binding
assay, a-IgA-inhibition binding assay, G-PEG-test, PEG-precipitation
test, CIq-ELISA-test, and the indirect granulocyte phagocytosis test
(IGPT). Positive results related to disease activity were obtained only in
the IGPT. In this test normal granulocytes are incubated for 1 hr with
patient serum. Thereafter, cells with cytoplasmic inclusions of immu-
noglobulin are detected by fluorescent antibodies and scored. In pa-
tients with WG, IgG-containing inclusions with a specific morphology
could be observed. No 1gM or IgA was present. After an incubation of
only 5 instead of 60 mm, the fluorescence pattern was more diffuse. This
pattern could also be observed when sera were incubated with ethanol-
fixed granulocytes and monocytes. The active material was isolated
within the IgG peak after ACA34 gelfiltration. Positivity could also be
obtained with Fab2 fragments. All patients with symptoms had signifi-
cantly higher ACPA titers than patients without symptoms (P < 0.01).
Moreover, a rise in ACPA titer seemed to predict recurrence of the
disease in WG patients without disease activity. ACPA could not be
demonstrated in the sera of more than 10,000 blood donors, 35 SLE
patients, 35 patients with seropositive rheumatoid arthritis, and 10
patients with idiopathic proliferative glomerulonephritis. ACPA seem
to be a new, specific marker for active WG and could be of major
importance in the pathogenesis of the disease.
Pharmacokinetics and nephrotoxicity of cyclosporin A in renal trans-
plant recipients. F. C. Henny. C. H. Kleinbloesem, A. J. Moolenaar, L.
C. Paul, D. D. Breimer, and L. A. van Es. Departments of Nephrology
and Chemical Pathology, University Hospital Leiden, Department of
Pharmacology, Subfaculty of Pharmacy, University of Leiden, The
Netherlands. The use of cyclosporin A (CsA) after renal transplantation
requires extensive knowledge about the pharmacokinetic parameters to
design optimal therapeutic regimens. We studied the pharmacokinetics
ofCsA in 14 renal transplant patients on low doses of prednisone during
a 3-month period of treatment. Three and 15 days after transplantation,
12-hr blood level studies of the drug were performed to calculate the
elimination half-life, area under the curve (AUC), and total blood
clearance; trough levels were measured twice weekly. In ten patients
terminal half-lives as well as the change in renal function were calcu-
lated after discontinuation of CsA treatment. The CsA levels were
measured in whole blood by radioimmunoassay. In the course of CsA
treatment, prolongation of half-life was found in most patients (6.3
3.2 hr on day 3 vs. 8.7 4.3 on day 15; mean SD) with a significant
decrease in clearance (46 17 1/hr on day 3 vs. 28 10 1/hr on day 15;
P < 0.02). This resulted in a continuous increase in the CsA blood level.
The terminal half-life varied considerably among the patients (24 to 93
hr). A good correlation (r = 0.9589) was observed between CsA trough
levels before discontinuation of CsA and the percent increment in
endogenous creatinine clearance after 2 weeks. The results of this study
show that during chronic CsA therapy there is a gradual increase in the
CsA blood level with a decrease in clearance at a specific CsA blood
level which is suggestive of nonlinear kinetics. Furthermore, whole
blood trough levels correlate with reversible nephrotoxicity and, in the
absence of rejection, allow to predict the renal allograft function after
discontinuation of CsA therapy.
Genetic control of the immune response against a non-MHC renal
endothelial antigen in the rat. J. J. Blankert, L. A. van Es, and L. C.
Paul. Department qfNephrology, University Hospital Leiden, Leiden,
The Netherlands. Immunization of MAXX (RT1) rats with spleen and
lymph node cells from BN (RTl) results in the formation of antibodies
directed against a non-MHC alloantigen on capillary and venous
endothelium (End) of the BN kidney. Since the MAXX and WAG
(RTP') strains are responders for this antigen, whereas the ACI (RTl)
strain is a non-responder, the genetics of the in vivo humoral immune
response was investigated in 43 (MAXX x ACflF2 and 13 (MAXX X
ACI)F1 x ACI backcrosses; since 0/16 RTl' animals formed End-
antibodies, whereas 38 of 40 rats that carried the RTI" haplotype in a
homozygous or a heterozygous form produced antibodies, the RTI
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haplotype was needed for a response. Using the informative MHC
recombinant strains DA.BI and WRC, the immune response gene was
mapped within the class II region of the MHC. Immunizations in
various MHC-incompatible combinations showed that only the MHC of
the recipient determines whether a response to the End antigen occurs,
whereas the donor MHC appears irrelevant.
Passive transfer of cytomegalovirus infection by kidney transplanta-
tions. H. Bruning, C. A. Bruggeman, and P. J. C. van Breda Vriesman.
Departments of Microbiology and Experimental Immunology, State
University of Limburg, Maastricht, The Netherlands. Lewis (LEW)
rats were infected with rat cytomegalovirus (RCMV). When the infec-
tion had become latent (immune T cells and antibody to RCMV
positive, no virus demonstrable by cocultivation techniques) or chronic
(immune T cells and antibody to RCMV positive, virus only demon-
strable in the salivary glands), the rats were used as donors for grafts.
Brown Norway (BN) rats or LEW were recipients. Immunodeficient
(500 Rad total body irradiation at the time of transplantation) BN
recipients of LEW kidneys taken from chronically infected LEW
donors showed RCMV in spleen (two of three) and salivary glands
(three of three) in high numbers when tested by plaque assay at 3 weeks
postoperatively. Immunodeficient BN recipients of latently or chroni-
cally infected LEW hearts failed to show RCMV (six of six). In the
absence of immunosuppression syngeneic LEW recipients of chroni-
cally or latent infected LEW renal allografts showed RCMV infection in
4 out of 11 instances; few plaques were seen and in the salivary glands
only. The results suggest that the transfer of latent infection by means
of organ transplants is a relative organ-specific phenomenon, amplified
by histoincompatibility. Apart from organ-specific organelles, differ-
ences in recirculating mobile passenger lymphocytes may be reponsible
for the observed organspecificity.
The role of acetate in inducing myocardial depression during
hemodialysis for acute renal failure. K. M. L. Leunissen, S. J. Hoorntje,
H. A. Fiers, W. T. Dekkers, and A. W. Mulder. Catharina Hospital,
Eindhoven, The Netherlands. Hemodynamic instability is the major
problem during hemodialysis of critically ill patients. Acetate in the
dialysate seems to play a pivotal role in this phenomenon. We com-
pared 12 pairs of randomly performed alternating recirculation acetate
dialysis (Ac-D) and bicarbonate dialysis (Bc-D) in nine patients with
acute renal failure. Invasive hemodynamic monitoring was performed.
Serial measurements of acetate blood levels, acid-base balance, and
blood gases were done during both types of dialysis. A significant
decrease in mean arterial pressure (MAP) and left ventricular stroke
work index (LVSWI) during Ac-D was observed, whereas during Bc-D
no significant hemodynamic changes were measured.
Hr D MAP, mm Hg LVSWI, U
0 Ac
Bc
90.2 3.9
88.4 5.5
69.4 4.9
68.1 7.9
MAP, mm Hg %iLVSWI
0.5 Ac
Bc
—14.1 4.1
—1.4 2.3*
—32.7 6.3
—5.5 6.4°
1 Ac
Bc
—11.7 2.7
+ 1.5 2.8*
—32.8 6.3
—2.1 7.4°
*p < 0.02. °P < 0.01.
Hemodynamic instability during Ac-D must be a consequence of an
impairment of cardiac performance since LVSWI decreased signifi-
cantly, whereas heart rate, systemic vascular resistance, and cardiac
filling pressures did not change. Except one, all patients failed to
achieve peak acetate levels of 5.1 mmoles/liter when the rate of acetate
infusion approximates maximum utilization. We observed a significant
drop in carbon dioxide tension from 30.2 1.7 to 26.1 1.0 (P <0.05)
and oxygen tension from 99.0 5.1 to 83.6 4.5 (P < 0.05) mm Hg
during Ac-D in the first hour of dialysis. There was no significant change
in pH during Ac-D. However, during Bc-D there was a significant
increase and complete correction of the acidosis in all patients. We
conclude that during Ac-D there is a decreased cardiac performance
while during Bc-D there is a stable hemodynamic state. The acetate-
induced hypocapnia, hypoxemia, and incomplete correction of the
acidosis are known to interfere with optimal cardiac performance.
Whether or not acetate itself is cardiodepressive in individual cases
needs further investigation.
Evaluation of three immunochemical methods to determine the selectiv-
ity index of urinary proteins. T. Ockhuizen, M. Haas, J. Mulder, S.
Meyer, G. K. van der Hem, and D. de Zeeuw. University Hospital,
Groningen and Laboratory of Public Health, Leeuwarden, The Neth-
erlands. Renal clearances (CI) of endogenous proteins are used fre-
quently to determine defects in size-selectivity of the glomerular
basement membrane. The selectivity index (SI) is usually expressed as
Cl-IgG/Cl-albumin. We evaluated the effect of three immunochemical
techniques on the outcome of the SI in 34 patients with varying
proteinuria (3 to 15 g/day): radial immunodiffusion (RID), electro-
immunodiffusion (EID), and nephelometry (NEPH). The SI values from
RID data correlated poorly with those from EID data (r = 0.33). Similar
results were found for RID versus NEPH (r = 0.22), and EID versus
NEPH (r = 0.00). Comparing the renal Cl of albumin measured by these
methods, good correlations were found. IgG-Cl, however, correlated
poorly, predominantly due to a distinct discrepancy between RID, EID,
and NEPH with respect to urinary IgG-concentrations. Isoelectric
focusing and two-dimensional electrophoresis (viz, charge and molecu-
lar weight) of blood and urine samples followed by immunospecific
staining on nitrocellulose blots, showed interindividual variations in
size and charge of urinary IgG. Preliminary results show that in vitro
modification of the charge of urinary IgG changed the concentration
measured. In conclusion, measurement of size-selectivity of the
glomerular basement membrane using renal clearances of albumin and
IgG fluctuated with the immunochemical method used, which was
predominantly due to the physico-chemical properties of IgG.
Nephrotoxicity of aminoglycosides comparing young and adult rats. A.
P. Provoost, 0. Adejuyigbe, E. D. Wolff, andJ. C. Molenaar. Depart-
ments of Pediatric Surgery and Pediatrics, Erasmus University, Rot-
terdam, The Netherlands. A comparison was made between the
nephrotoxic effects of the aminoglycoside antibiotics Gentamicin (G)
and Amikacin (A) in young and adult rats of a Wistar strain. At the start
of the experiments adult rats were about 3 months old with a body
weight of 300 g. Young rats were 4 weeks old with a body weight of 50
g. The G and A were injected subcutaneously once daily for 14 days.
The dosage of G was either 20 (G20) or 60mg/kg/day (G60), while A was
given in doses of 60 (A60) or 180 mg/kg/day (A180). The GFR and the
ERPF were measured during and after treatment with a method
allowing for repeated use in the same animal. The levels of G and A in
plasma and renal tissue were measured by EMIT assay. In adult rats
G20 caused a 20% drop in the GFR at day 14 and little change in the
ERPF, while after G60 there was a severe drop both in GFR and ERPF
of about 80% at days 11 and 14. There was no change in the GFR and
ERPF after A60, while in A180-treated rats a 50% reduction was noted
at day 14. Both the GFR and ERPF recovered completely, except for a
20% reduction in the GFR remaining in the adult rats treated with G60.
In contrast, in young rats a 20% drop was noted in the GFR at day 14
after G60, only with complete recovery after cessation of treatment.
After G20, A60, or A 180, the GFR and ERPF did not differ from that of
controls. To investigate the divergence of nephrotoxicity between
young and adult rats we measured the drug levels in renal tissue. After
identical doses, these levels were lower in the kidneys of young rats,
amounting to about 50% of that of adult rats. The renal uptake (as a
percentage of the injected dose) of the first drug dosage was comparable
in young and adult rats. We think that the larger amount of renal tissue
per unit of body weight may account for the lower drug level in the
kidneys of young rats. In conclusion, in rats, at equipotent dosages,
amikacin is less nephrotoxic than gentamicin. In young rats aminogly-
cosides are less nephrotoxic than in adult ones.
Volumetrical microcomputer-based ultrafiltration monitor for
hemodialysis. J. M. P. Wokke, J. H. M. Berden, and R. A. P. Koene.
Department of Physiology, School of Medicine, and Department of
Nephrology, St. Radboudziekenhuis, University of Nümegen,
Nijmegen, The Netherlands. Uniform and controlled ultrafiltration
during hemodialysis will lead to a decrease of dialysis side effects. One
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of the prerequisites for this treatment is an accurate measurement of
ultrafiltration. The best method currently available for ultrafiltration
measurement is based on the volumetrically measured change in
dialysate flow over the dialyzer. We developed an ultrafiltration moni-
tor (UFM) for hemodialysis using two micro-oval flowmeters measuring
the flow rate of the dialysate entering and leaving the dialyzer. Correc-
tion for the intrinsic error was performed with a microcomputer
(Acorn), in a calibration situation without ultrafiltration and constant,
equal flow through both flow transducers. The accuracy of the UFM in
vitro was 99.4% of the mean of total ultrafiltration, and showed a
correlation coefficient of 0.998 (N = 8) with the actual ultrafiltration. In
viva, where UFM was compared with bed scale body weight monitor-
ing, a correlation coefficient of 0.97 was found, and an accuracy of 90%
of total ultrafiltration as measured by the change in body weight (N =
82). Therefore, this UFM provides a cheap and reliable method for
ultrafiltration measurement.
Is there any correlation between the rise of serum aluminum after
desferrioxamine and bone aluminum content? J. van der Meulen, P.
Lips, and P. L. Oe. Department of Internal Medicine, Free University
Hospital, Amsterdam, The Netherlands. Prospectively we compared
the desferrioxamine (DFO) provocation test as an index of tissue
overload with repeated basal serum aluminum (SAL). In 20 adult
hemodialysis patients taking 8.5 to 60 mg elemental aluminum/kg/day,
sAL was measured as follows: if sAL was less than 150 ng/ml, sAL was
repeated after 3 months. in case sAL was greater than 150 ng/ml, it was
remeasured after 1 month. Whenever sAL was greater than 100 ng/ml at
two consecutive measurements, a provocation test was performed. In
the remaining patients this test was done after 1 year. The DFO
provocation test consisted of a 2-hr infusion of 4 g DFO at the beginning
of dialysis. The rise of sAL (sAL) 48 to 72 hr after DFO is claimed to
be the most relevant parameter. Basal sAL was defined as sAL
measured at a constant aluminum intake for at least 4 weeks. Bone
aluminum content was measured in iliac crest biopsy specimens by
neutron activation analysis. In six patients this biopsy was done, in four
because sAL was above 150 ng/ml. The two other patients, serving as
controls, had a sAL of 43 and 95 ng/ml. In these six patients basal sAL
varied from 42 to 244 ng/ml and bone aluminum from 19 to 76 sg/g wet
tissue. Bone aluminum content correlated positively with the mean
value of the sAL of the individual patient (r 0.88, P < 0.01). There
was no correlation with zsAL. Regarding sAL and aluminum intake, in
11 patients there was a fixed ratio between sAL (ng/ml) and daily
consumption of elemental aluminum (mg/kg), whereas in nine this ratio
changed. Besides this individual difference in fixed and fluctuating
ratios, in five patients this ratio was more than 2.6 on four occasions,
whereas in three patients it was always below 1.3. These eight patients
had nearly identical serum phosphate levels, so these different ratios are
not likely to be due to differences in compliance. One may conclude
from these results that the rise of sAL after DFO does not correlate with
bone aluminum content. High basal sAL suggests bone aluminum
accumulation, which may occur in some patients with relatively low
doses of aluminum.
Changes in plasma volume and renin activity during correction of
edema in the nephrotic syndrome (NS). A. B. Geers, H. A. Koomans, J.
C. Roos, ndE. J. Dorhout Mees. Deparunent of Nephrology, Univer-
sity Hospital, Utrecht, The Netherlands. In 20 NS patients we studied
changes in plasma volume (PV) and extracellular volume (ECV) (t3hI
albumin and 82Br-distribution spaces, respectively) as well as plasma
renin activity (PRA) and plasma aldosterone (PA), colloid osmotic
pressure (COP) and blood pressure (BP). Patients were treated with
diuretics, and PV and ECV were measured before and during treat-
ment, and after becoming edema-free (four observations per patient).
PV never decreased to values below normal, even in patients (N = 7)
with a persistent low COP (4.8 to 9 mm Hg) during this procedure. PV
was on average higher during massive edema (ECV 170 22%) than in
the edema-free state. BP was elevated slightly during edema and
decreased (but not below normal) during treatment. PRA and PA rose
progressively concomitant with the decrease of ECV. PRA was cor-
related strongly with ECV (r =
—0.60, P < 0.002). When compared with
eight normal subjects on a salt-free (20 mmoles NaCl/day), normal (200
mmoles), and high salt diet (1200 mmoles), PRA and PA were always
higher for the degree of ECV expansion. It is concluded that mainte-
nance of a normal PV in the NS does not depend on an expansion of
ECV. PRA is inappropriately high at all levels of ECV expansion,
which may explain the relatively elevated BP in these patients.
Renal reserve filtration capacity: Can it be measured? P. ter Wee, W.
Sluiter, and A. Donker. Department of Nephrology, State University
Hospital, Groningen, The Netherlands. GFR of living related donors
after kidney donation amounts to 70% of the value before
uninephrectomy. This indicates that in healthy individuals "dormant
filtration capacity" is available. Both an increase in glomerular blood
flow and a rise in filtration pressure can increase GFR. Low-dose
dopamine (D) is well-known to increase renal blood flow. Amino acids
(AA) on the other hand are thought to cause afferent vasodilation.
Therefore, a low dose of D (1.5 to 2.0 sg/kg/min) and an AA solution
(Vamin®N; 500 ml/6 hr for 18 hr) were infused separately (N = 165 and
51, respectively) or combined (N = 45) during a simultaneous measure-
ment of the GFR and the effective renal plasma flow in healthy
volunteers, in healthy individuals after uninephrectomy, and in renal
patients with varying degrees of renal insufficiency. During both D and
AA infusion, GFR increased significantly in healthy volunteers (12.5 vs.
14.5%), but most during combined infusion (24.5%). The effect of D and
AA on filtration fraction (FF) differed. D decreased FF, whereas FF
during AA infusion did not change or rose. During D a significant
increase of GFR was observed if base-line GFR amounted to greater
than or equal to SI ml/min/l.73 m2. There existed a positive relation
between the change in GFR and base-line GFR. In moderate to severe
renal insufficiency neither D nor AA or combined infusion increased
filtration. In patients with renal disease and a base-line GFR compa-
rable with that of healthy persons, the change in GFR during D was
significantly lower than in healthy volunteers. It is concluded that renal
reserve filtration capacity can be measured best with a combined
infusion of AA and D. Secondly, that early in renal disease a loss of
nephrons is compensated for, in which among others endogenous
dopamine release might be involved. A base-line GFR less than or equal
to 50 ml/min/l.73 m2 finally implies an exhaustion of so-called renal
reserve filtration capacity.
Long-term follow-up of living kidney donors; A two-center study. A. J.
Hoitsma, L. C. Paul, L. A. van Es, and R. A. P. Koene. Departments
of Medicine, Divisions of Nephrology, University Hospital Leiden and
Radboud Hospital, Nijmegen, The Netherlands. Recent experimental
studies indicate that renal ablation may initiate a progressive syndrome
of hypertension, proteinuria, and progressive azotemia. We therefore
studied the long-term follow-up data of living donors. Seventy-two
living related transplantations were performed in the two centers
between 1966 and June 1983. All donors who had undergone nephrec-
tomy more than I year ago were included in the present study. Twelve
donors refused further evaluation or could not be contacted. Forty-nine
donors were evaluated (26 males and 23 females). The age at the time of
nephrectomy varied between 21 and 55 years (mean, 39.3 8.7 years).
The follow-up period ranged from Ito 17 years (mean, 8.2 5.3 years).
The donor recipient combinations were either parent to child (N = 13)
or sibling to sibling (N = 36). At the time of follow-up eight donors had
proteinuria of more than 0.5 g/24 hr with the highest value of 1.8 g/24 hr.
In the urinary sediment of five donors more than five erythrocytes per
high power field were found. Comparison of mean systolic and diastolic
blood pressure before nephrectomy and at the time of the study showed
no significant changes. Two subjects required medication for a mild
hypertension. As expected, the mean serum creatinine increased sig-
nificantly immediately after nephrectomy (from 81 14 to 117 22
zmoles/liter). However, at the time of the study, the mean serum
creatinine had decreased significantly (105 22 zmoles/liter). These
data demonstrate that, although some donors had slight urinary ab-
normalities after unilateral nephrectomy, the risk to develop hyper-
tension was negligible, whereas deterioration of renal function, com-
pared with the postnephrectomy function, did not occur in any of the
donors. The glomerular hyperfiltration, which occurs after unilateral
nephrectomy, therefore has no demonstrable detrimental effect on the
function of the remaining kidney.
Effects of enalapril on serum K, renin-aldosterone system and intrare.
nal Na-handling in patients with Bartter syndrome (BS). R. J. Hené, H.
A. Koomans, A. v.d. Stolpen, G. E. G. Verhoef, and E. J. Dorhout
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Mees. Department of Nephrology, University Hospital, Utrecht and
Department of Internal Medicine, Leyenburg Hospital, The Hague,
The Netherlands. Six patients with BS were treated with enalapril, 20 or
40 mg/day. Before and after a 2 month treatment, electrolytes, blood
pressure (BP), plasma renin activity (PRA), plasma aldosterone (PAC),
extracellular volume (ECV). and angiotensin Ti sensitivity (Ails) were
determined. In three of them we investigated proximal Na-reabsorption
(PSR, I -[C(Na+ K) + CH2O/CIn]), distal Na-reabsorption (DSR,
CH2O/CH2O+CCI) during maximal water diuresis; free-water gener-
ated along the cortical distal tubule (CH2O-DT) was estimated as
previously described as was total body K (TBK).
Untreated Enalapril Ref. values
Serum K 2.5 0.4 4.0 0.5 3.8—5.0 mmoles/liier
PRA 7.2 2.8 14.4 3.4 0.2—0.8 pmoles/ liter/sec
PAC 663 278 190 39 100—500 pmoles/liter
ECV 270 22 264 29 302 19 mi/kg
Body wt 73.9 14.3 76.9 13.8 kg
AlT sens 34 12 11 4 lOng/mm/kg
BP 114
75
12/
8
113 11/
77 9
mmHg
PSR 0.91 0.02 0.90 0.03 0.82 0.06 mI/mm
GFR
DSR 0.83 0.05 0.72 0.11 0.85 0.04
CH2O-DT 3.9 1.3 3.3 0.8 9.7 4.7 mi/mm GFR
Though the BP dropped after the first dose, it returned to pretreatment
values within 3 days. Most subjects reported improved well being and all
gained weight, which was not due to an increase in ECV. TBK rose in
all three subjects (12 7%). Treatment did increase the distal tubular
defect (CH2O-DT); no changes were found in proximal reabsorption
and in ECV. Enalapril ameliorated potassium metabolism without
altering the abnormal intrarenal Na-handling, suggesting that the
hypokalemia is caused predominantly by a secondary hyperaldosteron-
ism.
Renal magnesium wasting in two different families with autosomal
dominant inheritance. W. Geven, L. Monnens, J. Wiilems, W. Buys,
and B. ter Haar. Department of Pediatrics, University of Nijmegen,
Nijmegen, The Netherlands. Magnesium depletion due to congenital
impairment in tubular reabsorption of magnesium is uncommon. Gener-
ally, it is part of a more extensive tubular disturbance. Isolated renal
magnesium loss was demonstrated in two different families with an
autosomal dominant mode of inheritance. Clinical symptoms were
lacking with the exception of pseudogout in the adult members of one
family. Magnesium absorption studies performed with 28-Mg showed
an increased intestinal absorption. The renal magnesium threshold as
well as TmMg, determined in one member of both families, were
lowered. All the members of both families, who presented with
hypomagnesemia also had a lowered urinary excretion of calcium. This
decreased urinary calcium excretion is probably the consequence of an
increased calcium reabsorption in Henle's loop (see table below).
Family Serum Mg Mg excretion Ca excretion
1 0.40 1.7—2.6 0.4—0.6
2 0.38 2.2—3.0 0.1—0.2
Normal 0.75—1,25 0.9—5.2 1.2—7.3
values mmol/liter mg/kg/24 hr mg/kg/24 hr
The glomerular filtration rate, the 2microglobulin clearance and the
concentrating capacity were normal. Glucosuria, proteinuria, and
hyperaminoaciduria were absent.
